Cytokinetics
CYTK
CYTK
127 hedge funds and large institutions have $266M invested in Cytokinetics in 2018 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 37 increasing their positions, 42 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
12% less repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 42
15% less capital invested
Capital invested by funds: $315M → $266M (-$48.2M)
18% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 22
Holders
127
Holding in Top 10
1
Calls
$973K
Puts
$1.1M
Top Buyers
| 1 | +$852K | |
| 2 | +$591K | |
| 3 | +$567K | |
| 4 |
Invesco
Atlanta,
Georgia
|
+$547K |
| 5 |
Millennium Management
New York
|
+$543K |
Top Sellers
| 1 | -$3.48M | |
| 2 | -$2.55M | |
| 3 | -$1.71M | |
| 4 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
-$1.53M |
| 5 |
Squarepoint
New York
|
-$1.14M |